These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39150581)

  • 21. Screening and identification of potential inhibitor for visceral leishmaniasis (VL) through computational analysis.
    Shaslinah N; Sangavi P; Sangeetha R; Gowthamkumar S; Sindhu V; Langeswaran K
    J Genet Eng Biotechnol; 2022 Feb; 20(1):35. PubMed ID: 35195803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting
    Sakyi PO; Kwofie SK; Tuekpe JK; Gwira TM; Broni E; Miller WA; Wilson MD; Amewu RK
    Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of
    Phan TN; Park KP; Shum D; No JH
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
    Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
    Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monomethylsulochrin isolated from biomass extract of
    Silva-Silva JV; Moreira RF; Watanabe LA; de Souza CDSF; Hardoim DJ; Taniwaki NN; Bertho AL; Teixeira KF; Cenci AR; Doring TH; Júnior JWDC; de Oliveira AS; Marinho PSB; Calabrese KDS; Marinho AMDR; Almeida-Souza F
    Front Cell Infect Microbiol; 2022; 12():974910. PubMed ID: 36093206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase.
    Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK
    Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Novel Flavonoids and Ansa-Macrolides with Activities against
    Phan TN; Lee H; Baek KH; No JH
    Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from
    Wadanambi PM; Mannapperuma U
    Heliyon; 2021 Jun; 7(6):e07178. PubMed ID: 34141935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.
    Muhammad MT; Ghouri N; Khan KM; Arshia ; Choudhary MI; Perveen S
    Med Chem; 2018; 14(7):725-732. PubMed ID: 29332596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
    Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents.
    Ansari SB; Kamboj S; Ramalingam K; Meena R; Lal J; Kant R; Shukla SK; Goyal N; Reddy DN
    Bioorg Chem; 2023 Aug; 137():106593. PubMed ID: 37186964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro biological evaluation of 3,3',5,5'-tetramethoxy-biphenyl-4,4'-diol and molecular docking studies on trypanothione reductase and Gp63 from Leishmania amazonensis demonstrated anti-leishmania potential.
    Schirmann JG; Bortoleti BTS; Gonçalves MD; Tomiotto-Pellissier F; Camargo PG; Miranda-Sapla MM; Lima CHS; Bispo MLF; Costa IN; Conchon-Costa I; Pavanelli WR; Dekker RFH; Barbosa-Dekker AM
    Sci Rep; 2023 Apr; 13(1):6928. PubMed ID: 37117253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani.
    Hazra S; Ghosh S; Das Sarma M; Sharma S; Das M; Saudagar P; Prajapati VK; Dubey VK; Sundar S; Hazra B
    Exp Parasitol; 2013 Oct; 135(2):407-13. PubMed ID: 23973194
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Tadele M; Abay SM; Makonnen E; Hailu A
    Drug Des Devel Ther; 2020; 14():1307-1317. PubMed ID: 32280200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
    Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
    J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmanicidal Potential of Hardwickiic Acid Isolated From
    Crentsil JA; Yamthe LRT; Anibea BZ; Broni E; Kwofie SK; Tetteh JKA; Osei-Safo D
    Front Pharmacol; 2020; 11():753. PubMed ID: 32523532
    [No Abstract]   [Full Text] [Related]  

  • 37. Triose Phosphate Isomerase Structure-Based Virtual Screening and In Vitro Biological Activity of Natural Products as
    González-Morales LD; Moreno-Rodríguez A; Vázquez-Jiménez LK; Delgado-Maldonado T; Juárez-Saldivar A; Ortiz-Pérez E; Paz-Gonzalez AD; Lara-Ramírez EE; Yépez-Mulia L; Meza P; Rivera G
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bio-guided isolation of anti-leishmanial natural products from Diospyros gracilescens L. (Ebenaceae).
    Njanpa CAN; Wouamba SCN; Yamthe LRT; Dize D; Tchatat BMT; Tsouh PVF; Pouofo MN; Jouda JB; Ndjakou BL; Sewald N; Kouam SF; Boyom FF
    BMC Complement Med Ther; 2021 Mar; 21(1):106. PubMed ID: 33789661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity.
    Ramu D; Garg S; Ayana R; Keerthana AK; Sharma V; Saini CP; Sen S; Pati S; Singh S
    Biochem Pharmacol; 2017 Apr; 129():26-42. PubMed ID: 28017772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.